Consumption of antidepressants in Chile from 1992 to 2004;Consumo de antidepresivos en Chile entre 1992 y 2004

Revista Medica de Chile

Volumn 136, Issue 9, 2008, Pages 1147-1154

  Jrón, Marcela ^a   Machado, Márcio ^b   Ruiz, Inés ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antidepressive agents; Fluoxetine; Mood disorders

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CHILE; CLINICAL PRACTICE; DEPRESSION; DRUG COST; ECONOMICS; FEMALE; HUMAN; MALE; STATISTICS; TIME;

ANTIDEPRESSIVE AGENTS; CHILE; DEPRESSIVE DISORDER; DRUG COSTS; FEMALE; FLUOXETINE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 56349157897     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. BERGMAN U, GRIMSSON A, WAHBA AW, WESTERHOLM B. Studies in Drugs Utilization: Methods and Applications. Regional Publication, European Series No 8, Copenhagen. World Health Organization. Regional Office for Europe. 1979.
2. Situación de Salud en Chile 1999. Tarjeta de presentación. Ministerio de Salud. Chile. 2000.
3. Ministerio de Salud. División de Salud de las Personas. Programa de Salud del Adulto. MINSAL, Santiago, Chile. 1999.
4. Encuesta Nacional de Salud 2004. Ministerio de Salud. Chile. 2004.
5. VICENTE B, KOHN R, RIOSEOO P, SALDIVIA S, TORRES S. Lifetime and 12-Month Prevalence of DSM-III-R Disorders in the Chile Psychiatric Prevalence Study. Am J Psychiatry 2006; 163: 1362-70.
6. FLORENZANO R, ACUÑA J, PULLERTON C, CASTRO C. Estudio comparativo de frecuencia y características de los trastornos emocionales en pacientes que consultan en el nivel primario de atención en Santiago de Chile. Rev Méd Chile 1998; 126: 397-405.
7. COMETON MT, NEMEROPF CB. The Evaluation and Treatment of Depression in Primary Care. Clin Cornestone 2001; 3: 10-22.
8. Situación del medicamento en Chile, División de Salud de las Personas, Departamento Programa de las Personas. Ministerio de Salud Chile. 1999.
9. LMS Health Database, www.imshealth.com
10. ATC classification index with DDDs: Guidelines for ATC classification and DDD assignment WHO Collaborating Centre for Drug Statistics Methodology. January 2004.
11. Chile: Anuario de Estadísticas Vitales 2000. Instituto Nacional de Estadísticas. Ministerio de Salud. Chile. 2002.
12. HEMELS ME, KOREN G, EINARSON TR. Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother 2002; 36: 1375-9.
13. PATTEN SB. The duration of major depressive episodes in the Canadian general population Chronic Dis Can 2001; 22: 1-6.
14. STEPHENS T, JOUBERT N. The economic burden of mental health problems in Canada. Chronic Dis Can 2001; 22: 18-23.
15. JUDD LL, PAULUS MJ, SCHETTLER PJ ET AL. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000; 157: 1501-4.
16. OLIE JP, ELOMARI F, SPADONE C, LEPINE JP. Antidepressants consumption in tine global population in France. Encephale 2002; 28: 411-7.
17. MA J, LEE KV, STAFFORD RS. Depression treatment during outpatient visits by U.S. children and adolescents. J Adolesc Health 2005; 37: 434-42.
18. MCMANUS P, MANT A MTCHELL PB, MONTGOMERY WS, MARLEY J, AULAND ME. Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Med J Aust 2000; 173: 458-61.
19. JIRÓN M Prevalencia de consumo de antidepresivos en la población mayor de 15 años de Santiago. Tesis (Magíster en Ciencias, mención Epidemiología Clínica). Santiago, Chile. Universidad de Chile. Facultad de Medicina, 2004. 88 h.
20. MACHADO M, LSKEDJIAN M, RUIZ I, EINARSON TR Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of headto-head trials. Curr Med Res Opin 2006; 22: 1825-37.
21. Decreto Supremo 1506. Ministerio de Salud de Chile. Modifica reglamento de estupefacientes y psicotrópicos. Diario Oficial 30 de septiembre de 1993.
22. Banco Central de Chile. Base de Datos Estadísticos. Available at http://si2.bcentral.cl/Basededatoseconomicos (consultado el 3 de septiembre de 2006)
23. MACHADO M ISKEDJIAN M EINARSON TR. Quality assessment of published health economic analyses from South America. Ann Pharmacother 2006; 40: 943-9.
24. MACHADO M, ISKEDJIAN M RUIZ I, EINARSON TR. The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary: Cost-Effectiveness and Budget-Impact Analyses. Pharmacoeconomics 2007; 25: 979-90.